Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
A growing body of evidence links Chlamydia pneumoniae to the progression of coronary heart disease. The purpose of this study is to determine the positive and negative effect of 14 days treatment with clarithromycin 500 mg daily in patients already suffering from stable coronary heart disease. The participants will be followed for at least two years after the treatment. Abbott Laboratories supplied Clarithromycin and placebo tablets.
Critère d'inclusion
- Heart disease,cardiovascular disease